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SUMMARY
Infections with Vibrio spp. have frequently been associated with consumption of bivalve molluscs, 
especially oysters, but illness associated with clams has also been well documented. We describe 
the 2312 domestically acquired foodborne Vibrio infections reported to the Cholera and Other 
Vibrio Illness Surveillance system from 1988 to 2010. Clams were associated with at least 4% (93 
persons, ‘only clams’) and possibly as many as 24% (556 persons, ‘any clams’) of foodborne 
cases. Of those who consumed ‘only clams’, 77% of infections were caused by V. 
parahaemolyticus. Clam-associated illnesses were generally similar to those associated with other 
seafood consumption. Clams associated with these illnesses were most frequently harvested from 
the Atlantic coastal states and eaten raw. Our study describes the contribution of clams to the 
overall burden of foodborne vibriosis and indicates that a comprehensive programme to prevent 
foodborne vibriosis need to address the risks associated with clams.
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INTRODUCTION
Vibrio spp. cause illnesses that result in substantial morbidity and mortality. Although 
cholera, caused by toxigenic V. cholerae O1 or O139, is a major global problem, it is rare in 
the USA. On the other hand, vibriosis – infection caused by any species or strain of 
Vibrionaceae other than those that cause cholera – is an important public health problem in 
the USA. Most notably, V. vulnificus infection causes high rates of mortality and severe 
illness, usually in persons with underlying health conditions. Vibriosis is frequently 
associated with bivalve mollusc consumption [1–8]. Infections with Vibrio spp. have 
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frequently been associated with consumption of oysters [1, 5, 8], but illness associated with 
clam consumption has also been well documented [2, 4, 6, 7]. Vibrios are ubiquitous in 
marine and estuarine environments. Vibrio abundance in the environment and seafood, 
along with vibriosis incidence, peak in the summer when water temperatures are warmest.
The Cholera and Other Vibrio Illness Surveillance system (COVIS) is a collaborative 
reporting system initiated in 1988 by Gulf Coast states (Alabama, Florida, Louisiana, 
Texas), the Centers for Disease Control and Prevention (CDC), and the US Food and Drug 
Administration (FDA). COVIS includes surveillance for toxigenic V. cholerae O1 and 
O139, which cause cholera. Surveillance also includes vibriosis caused by infection with V. 
alginolyticus, V. cholerae (all strains other than those that cause cholera), V. 
parahaemolyticus, V. vulnificus, and all other members of the genus Vibrio as well as 
Photobacterium damselae subsp. damselae (formerly V. damsela) and Grimontia hollisae 
(formerly V. hollisae). Nearly all states had begun reporting vibriosis to COVIS by the early 
2000s. In 2007, the Council of State and Territorial Epidemiologists issued a position 
statement making all Vibrio infections nationally notifiable; in 2010 the position statement 
was updated to reflect taxonomic changes [9].
METHODS
Information reported to COVIS by state and local health officials includes demographic, 
isolate (i.e. species and clinical site of specimen), clinical, and risk exposure information as 
well as seafood traceback information when available. Demographic information collected 
includes patient’s age, sex, race, and ethnicity. The specific Vibrionaceae isolated and the 
date of specimen collection are also captured. Clinical information includes symptom onset 
date, duration of illness, pre-existing comorbid conditions, medications used within 30 days 
before illness onset, hospitalization, and mortality. Risk exposure information includes 
seafood consumed, interstate and international travel history of the patient, exposure to 
bodies of water and marine life – all within 7 days before illness onset – and whether the 
case was associated with an outbreak. For patients with seafood exposure, detailed 
information about its preparation (i.e. cooked vs. raw), source, and location consumed (i.e. 
home, restaurant, at a gathering, etc.) is collected. Harvest and shipment information from 
seafood tags (seafood traceback information) is also obtained from the location where 
suspect seafood was consumed.
We analysed data for cases of vibriosis reported to COVIS from 1988 to 2010. We excluded 
cases in which international travel within 7 days of illness onset was reported. We also 
excluded non-foodborne cases, those cases for which information on risk exposures was 
missing or the only reported risk exposures were direct contact with bodies of water, marine 
or estuarine life, or drippings from raw or live seafood. We classified the remaining cases 
(those reporting only seafood consumption, or seafood consumption and other risk 
exposures) as follows: for cases in which seafood consumption was the only risk exposure 
reported, we considered illness to be foodborne if (1) Vibrio was isolated only from a 
gastrointestinal or blood or other normally sterile site or, (2) if more than one specimen site 
was reported, a skin or soft tissue site was not reported and at least one site was 
gastrointestinal or other normally sterile site. For cases in which other risk exposures as well 
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as seafood consumption were reported, we considered illness to be foodborne if Vibrio was 
isolated from a gastrointestinal site and a skin or soft tissue site isolation was not reported. 
Thus, the study population includes only domestically acquired foodborne infection. The 
COVIS surveillance form includes the following types of seafood consumed: clams, crab, 
fish, lobster, mussels, oysters, shrimp, and ‘other seafood’. In our analysis clams were 
defined as bivalve molluscs living in sand or mud.
Of foodborne cases, we categorized clam consumption for those patients for whom 
information was available as ‘no clams’ or ‘any clams.’ Patients in the ‘any clam’ category 
reported clam consumption and were not excluded if they also reported other seafood 
consumption. We also defined a subset of patients in the ‘any clam’ category, i.e. those who 
reported ‘only clams’ and no other seafood consumption. We also performed a subanalysis 
of patients who reported consuming ‘only oysters’ and no other seafood consumption. We 
compared demographics (gender, age, race, ethnicity) and clinical information (duration of 
illness, hospitalization rate, mortality, underlying comorbid conditions), stratified by species 
isolated. For patients whose only seafood exposure was clams, we analysed seasonality of 
infections, clam preparation [i.e. raw vs. cooked (including steamed, baked, boiled, or 
fried)], and clam harvest site information from seafood tags. Additionally, we performed 
detailed subgroup analysis for the most commonly reported species, V. parahaemolyticus. 
Analyses were conducted using SAS v. 9.3 (SAS Institute, USA).
RESULTS
In total, 8455 cases of vibriosis in patients without a history of international travel were 
reported to COVIS from 1988 to 2010. Of these reports, 5376 (64%) were not classified as 
foodborne resulting in 3079 (36%) domestically acquired foodborne seafood (foodborne 
transmission) cases of vibriosis being analysed. Of these, information on clam consumption 
was available for 2312 (75%). Only these reports were included in the full analysis 
described below.
To compare clam-associated vibriosis to vibriosis associated with other kinds of seafood, we 
compared patients who reported consuming clams to those who did not. Of all 2312 reports 
specifying one or more seafood items consumed and for which information on clam 
consumption was available, 1756 (76%) reported ‘no clam’ consumption, 556 (24%) 
reported ‘any clam’ consumption, and, of these, 93 (4%) reported consuming ‘only clams’ 
and no other seafood. Therefore, 17% of clam consumers reported only eating clams. Table 
1 presents information on species of reports by clam consumption status. Persons who 
reported eating ‘only oysters’ and no other seafood were generally very similar to persons 
who reported eating ‘no clams’. V. parahaemolyticus was the species most commonly 
associated with clam consumption, accounting for 77% of reports of persons who reported 
eating ‘only clams’, somewhat higher than in the 65% who reported eating ‘no clams’. By 
contrast, V. vulnificus, the second most common species reported by persons with ‘any 
clam’ consumption, accounted for 7% of ‘any clam’ reports, somewhat less than the 10% in 
those with ‘no clam’ consumption (Table 1). V. vulnificus infections in persons with ‘only 
clam’ consumption were rare, with only four persons in this category. Vibrio illnesses in 
persons with ‘only clam’ consumption peaked in July and August (56% of reports were in 
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these two months), as did illnesses in individuals with ‘any clam’ consumption (52% of 
reports) and ‘no clam’ consumption (46% of reports).
Of foodborne vibriosis cases with information on clam consumption, isolation sites included 
gastrointestinal only (2049 reports, 89%), blood or other normally sterile site only (249 
reports, 11%), and multiple sites (14 reports, 1%, including seven reporting both blood and 
stool, two blood and peritoneal fluid, two blood and skin, one blood and bile duct, one blood 
and cerebrospinal fluid, and one stool and urine). Isolation site varied by species isolated; 
for all foodborne V. parahaemolyticus, ~99% of isolates were gastrointestinal, ~1% were 
blood or other normally sterile sites, and <1% were multiple sources. Conversely, for 
foodborne V. vulnificus, 84% of isolates were from blood or other normally sterile sites, 
14% gastrointestinal, and 2% multiple sources. In general, isolation site did not vary 
substantially by clam consumption within species categories.
Table 2 presents demographic and clinical characteristics for V. parahaemolyticus. A 
somewhat higher proportion of patients reporting ‘only clam’ consumption reported any pre-
existing condition (43% in patients with ‘only clam’ consumption vs. 34% with ‘no clam’), 
notably with diabetes mellitus (12% vs. 7%). The proportion hospitalized was higher for 
those who consumed ‘only clams’ compared to ‘no clams’ (29% vs. 19%) although the 
median duration of illness was slightly shorter (5 days vs. 7 days).
To assess the harvest sites and preparation of clams consumed by patients with vibriosis 
who consumed ‘only clams’, we quantified these parameters. Of the 93 ‘only clam’ cases, 
37 reports had harvest site information available. These reports showed that clams were 
most often harvested from the Atlantic Coast (29 reports, 83%), although harvest sites in the 
Pacific (four reports, 11%) and Gulf (two reports, 6%) coasts were also reported. For reports 
(29 reports) with harvest sites in the Atlantic, the species reported were: 23 V. 
parahaemolyticus, three non-toxigenic V. cholerae non-O1, non-O139 serogroups, two V. 
fluvialis, and one V. alginolyticus. All reports (four reports) from harvest sites in the Pacific 
were V. parahaemolyticus, and of the two reports from Gulf Coast harvest sites, one was V. 
parahaemolyticus and one was V. vulnificus. Two ‘only clam’ patients consumed clams that 
were imported: one patient consumed clams from Canada and one from clams from New 
Zealand. Of the ‘only clam’ persons for whom information about clam preparation was 
available (n = 76), 88% (67/76) reported eating clams raw, 5% (four persons) steamed, and 
7% baked, boiled, or fried. The number of clams consumed varied widely (range 2–300, 
median 12 clams). Demographics of persons who reported consuming raw vs. cooked clams 
were similar: median age was 54 vs. 56 years, 77% vs. 71% male, and 85% vs. 83% white 
race, respectively. Of eight seafood tracebacks that included information about factors 
contributing to contamination, only a single case of ‘improper storage, cross-contamination, 
or improper holding temperature’ was reported.
DISCUSSION
Clam-associated infections account for a substantial minority of Vibrio illnesses. Of patients 
with foodborne seafood-associated vibriosis acquired in the USA, 24% of ill persons with 
any seafood consumption reported eating clams before becoming ill, and more than a sixth 
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of those reported eating only clams. For persons with V. parahaemolyticus infection, the 
most commonly reported species causing vibriosis, the proportion with clam exposure was 
even higher. More than 80% of patients with only clam consumption and information 
available ate clams harvested in the Atlantic, and almost 90% ate them raw. These data 
demonstrate the contribution of clams to the burden of vibriosis in the USA and provide 
direction for prevention measures.
Clam-associated vibriosis has received little attention in the scientific literature, although 
well-documented outbreaks have occurred. From 1973 to 2009, seven Vibrio outbreaks 
associated with clam consumption were reported by states to the CDC Foodborne Disease 
Outbreak Surveillance System (FDOSS) [10]. Six were caused by V. parahaemolyticus, 
ranging from 2 to 26 illnesses (median, four illnesses). Three of these outbreaks occurred in 
1982, one occurred in 1992, and the other two in 2006. Four outbreaks were associated with 
raw clams and two with steamed clams, indicating that even clams presented to the 
consumer as cooked can have associated health risks. Steamed clams may be undercooked 
or subject to cross-contamination by raw products. A seventh outbreak of two cases of non-
toxigenic V. cholerae O1 infection associated with clam consumption in a private home was 
reported in 1977. No clam-associated V. vulnificus outbreaks have been reported.
Our analyses are subject to several limitations. First, persons with more severe illness 
outcomes may be more likely to be diagnosed and be reported to COVIS than persons with 
less severe illness outcomes. However, this reporting bias is likely to impact all illnesses 
associated with different seafood commodities equally, so it is unlikely to change our 
conclusions regarding comparisons of clam-associated vs. other foodborne seafood-
associated vibriosis. Second, multiple seafood items are often served together at the same 
meal, and ill persons may not recall or report all seafood consumed. This may lead to 
misclassification of persons into ‘any’, ‘only’, and ‘no clam’ consumption categories. 
Nearly one quarter of reports were missing seafood exposure information and were not 
included in our analysis. Third, nearly two-thirds of reports from individuals who had 
consumed only clams did not have harvest site information available, which limits our 
ability to identify common harvest sites, and <10% had information on whether there was 
evidence of improper storage, cross-contamination, or improper holding temperature. 
Finally, vibriosis reporting practices vary by state and year. As a passive surveillance 
system, COVIS captures only illnesses that states report to CDC. Additionally, it is not 
known whether states not reporting cases to COVIS actually had no cases. This may lead to 
systematic underreporting of vibriosis, and there may be regional variations in reporting 
over time.
Historically, many vibriosis prevention programmes have focused on risk reduction 
strategies for raw oysters [11]. In the USA, the Interstate Shellfish Sanitation Conference 
(ISSC) establishes policy for molluscan shellfish safety (including oysters, clams, mussels 
and scallops) [12]. ISSC began implementing stricter time and temperature requirements and 
consumer education in the 1990s primarily to address the risk of V. vulnificus infection from 
oyster consumption in persons with pre-existing conditions such as liver disease and 
alcoholism. The current V. parahaemolyticus and V. vulnificus control plans, which were 
implemented in 2008 and 2010, respectively, address these risks with the consumption of 
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oysters only. Our analyses draw attention to the parallel risks associated with clam 
consumption, showing that clams, especially raw clams, are also an important source of 
vibriosis, especially V. parahaemolyticus infection. V. vulnificus infection was also 
associated with clam consumption, although rarely in patients with ‘only clam’ 
consumption.
The rarity of reported V. vulnificus infections associated with clams may reflect the fact that 
the major source of implicated clams was Atlantic rather than Gulf Coast waters. V. 
vulnificus illnesses are more frequently reported in residents of the Gulf Coast than the 
Atlantic Coast, regardless of type of seafood consumed (CDC, unpublished data). Moreover, 
a national study of bacterial pathogens in live oysters at retail establishments found that 
oysters harvested from Gulf Coast waters had significantly higher levels of V. vulnificus 
than oysters harvested from the Mid-Atlantic in the spring and autumn and from the North 
Atlantic year round [13]. By contrast, V. parahaemolyticus levels were highest in Mid-
Atlantic and Gulf oysters. Although this study focused on oysters, not clams, it suggests that 
environmental V. vulnificus levels in Gulf Coast waters may be higher than those in Atlantic 
waters. Since many species of clams for US consumption are primarily harvested from 
Atlantic waters, our findings may represent the distribution of pathogens in seafood beds 
[14]. Although data were limited, improper handling of clams was only documented in a 
single report of the eight reports that included information, suggesting that, as for other 
foodborne seafood-associated vibriosis, contamination was usually intrinsic. Risk reduction 
strategies focusing only on raw oyster consumption ignore an important vehicle for Vibrio 
illnesses. Comprehensive prevention programmes must address the risks associated with 
clams as well as oysters.
While our results are based on small numbers, they raise the question of whether clam-
associated V. parahaemolyticus infections might be more severe, on average, than those due 
to other kinds of seafood. About one third of patients reporting ‘only clam’ consumption 
were hospitalized, compared to one fifth of those with ‘no clam’ consumption, although the 
median duration of illness was also 2 days shorter for ‘only clam’ consumers. The most 
plausible explanation for this intriguing but unproven possibility would be that consumers 
may, on average, ingest a higher dose of vibrios with clams than with other seafood. This 
could occur if clams concentrate vibrios more than other seafood, such as oysters, if vibrios 
replicate more rapidly in post-harvest clams than in other seafood, or if consumers tend to 
eat more clams or more raw clams in a sitting than other seafood. Studies have examined the 
growth rates of vibrios in post-harvest oysters and have shown variability in virulence of 
sub-populations [15, 16], but similar studies have not been reported for clams. The ISSC is 
shifting from established illness reduction goals to a risk per serving approach for oysters 
[17], which could also be applied to clams. Our study results provide the strongest evidence 
to date that clams are an important vehicle of foodborne vibriosis in the USA.
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Table 1
Domestically acquired, seafood-associated vibrio infections, by species and by history of clam consumption, 













V. cholerae, non-toxigenic‖ 5 (5) 32 (6) 199 (11) 231 (10)
V. parahaemolyticus 72 (77) 426 (77) 1134 (65) 1560 (67)
V. vulnificus 4 (4) 37 (7) 170 (10) 207 (9)
Other¶ 12 (13) 61 (11) 253 (14) 314 (14)
Total 93 (4) 556 (24) 1756 (76) 2312 (100)
*
Ill persons reported clam consumption and reported that they did not consume any additional seafood items.
†
Ill persons reported clam consumption and were not excluded if they reported consuming any additional seafood items.
‡
Ill persons reported seafood consumption of crab, lobster, mussels, oysters, shrimp, crawfish, fish, and/or other shellfish, but not clams.
§
Sum of ‘any clam’ and ‘no clam’ consumption categories because ‘only clam’ is a subset of ‘any clam’.
‖
Includes non-toxigenic O1, O139, and non-O1, non-O139 V. cholerae.
¶
This category includes V. alginolyticus, V. cincinnatiensis, Photobacterium damselae subsp. damselae (formerly V. damsela), V. fluvialis, V. 
furnissii, Grimontia hollisae (formerly V. hollisae), V. metschnikovii, V. mimicus, Vibrio spp., multiple species, and other species.
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Table 2
Demographic and clinical characteristics of persons with Vibrio parahaemolyticus infection associated with 









Male 51/71 (72%) 715/1125 (64%) 1196
Age, median (range), N 50 (17–86), 71 44 (1–92), 1090 1161
Race
  White 49/53 (92%) 751/920 (82%) 973
  African-American 3/53 (6%) 83/920 (9%) 973
Hispanic 5/32 (16%) 54/316 (17%) 348
Any pre-existing condition‡ 31/72 (43%) 390/1135 (34%) 1207
  Diabetes 7/59 (12%) 73/1079 (7%) 1138
  Alcoholism 1/56 (2%) 30/1052 (3%) 1108
Duration of illness, days, median (range), N 5(1–30), 48 7 (<1–280), 969 1017
Isolation from blood§ 0/72 (0%) 14/1135 (1%) 1207
Hospitalized 19/47 (29%) 210/1117 (19%) 1164
Died 0/66 (0%) 5/1108 (0%) 1174
*
Ill persons reported clam consumption and reported that they did not consume any additional seafood items.
†
Ill persons reported seafood consumption of crab, lobster, mussels, oysters, shrimp, crawfish, fish, and/or other shellfish, but not clams.
‡
Defined as alcoholism, diabetes, peptic ulcer, gastric surgery, heart disease, haematological disease, immunodeficiency, liver disease, malignancy, 
and/or renal disease.
§
Includes persons with only blood isolates and persons with blood and other isolate.
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